Aether Industries Limited (BOM:543534)
India · Delayed Price · Currency is INR | Market Cap | 204.32B +100.6% |
| Revenue (ttm) | 12.30B +34.5% |
| Net Income | 2.35B +34.0% |
| EPS | 17.75 +34.2% |
| Shares Out | n/a |
| PE Ratio | 86.88 |
| Forward PE | 63.39 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 106,592 |
| Open | 1,524.85 |
| Previous Close | 1,489.25 |
| Day's Range | 1,491.10 - 1,613.00 |
| 52-Week Range | 723.15 - 1,613.00 |
| Beta | n/a |
| Analysts | Hold |
| Price Target | 1,402.83 (-10.81%) |
| Earnings Date | Jul 31, 2026 |
About Aether Industries
Aether Industries Limited produces and sells advanced intermediates and specialty chemicals in India and internationally. It also large-scale manufacturing, contract research and manufacturing services, as well as contract/exclusive manufacturing services. The company serves its products to the chemical industry, including multinational, regional, and domestic companies in the pharmaceuticals, agrochemicals, materials science, textiles, coatings, high-performance photography, additives, and oil and gas industries. It also exports its products. ... [Read more]
Financial Performance
In fiscal year 2026, Aether Industries's revenue was 11.60 billion, an increase of 38.02% compared to the previous year's 8.41 billion. Earnings were 2.19 billion, an increase of 38.53%.
Financial StatementsAnalyst Summary
According to 6 analysts, the average rating for 543534 stock is "Hold." The 12-month stock price target is ₹1,403, which is a decrease of -10.81% from the latest price.
News
Aether Industries Transcript: Q1 26/27
Q1 FY2027 saw 27% revenue and 33% PAT growth year-over-year, driven by strong CEM/CRAMS performance and new product launches. Major expansion projects are on track, and a landmark R&D partnership with Dow Chemical positions the company for leadership in advanced silicones and semiconductor materials.
Aether Industries Slides: Q1 2027
Aether Industries has posted slides in relation to its Q1 2027 quarterly earnings report, which was published on July 31, 2026.
Aether Industries Quarterly report: Q1 2027
Aether Industries has published its Q1 2027 quarterly earnings report on July 31, 2026.
Aether Industries Transcript: Q4 25/26
Revenue grew 38% year-over-year in FY 2026, with strong pricing and robust demand despite global disruptions. Major R&D and manufacturing expansions are underway, targeting a shift to 70% revenue from CRAMS and CM by FY 2030, while margins and cash flows remain healthy.
Aether Industries Quarterly report: Q4 2026
Aether Industries has published its Q4 2026 quarterly earnings report on May 15, 2026.
Aether Industries Slides: Q4 2026
Aether Industries has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 15, 2026.
Aether Industries Transcript: Q3 25/26
Q3 FY26 saw 44% revenue growth and 75% EBITDA growth year-over-year, driven by strong performance across all business segments and major capacity expansions. Outlook remains robust with new contracts, R&D investments, and a focus on non-pharma sectors, while sustainable EBITDA margins are guided at 29-30%.
Aether Industries Quarterly report: Q3 2026
Aether Industries has published its Q3 2026 quarterly earnings report on February 3, 2026.
Aether Industries Slides: Q3 2026
Aether Industries has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on February 3, 2026.
Aether Industries Transcript: Q2 25/26
Q2 FY 2026 saw 38% revenue growth and 70% EBITDA growth year-over-year, with CEM and CRAMS now over 50% of sales. CapEx and R&D expansions are on track, supporting a 25% annual growth outlook and sustainable 29%-31% EBITDA margins.
Aether Industries Quarterly report: Q2 2026
Aether Industries has published its Q2 2026 quarterly earnings report on November 13, 2025.
Aether Industries Slides: Q2 2026
Aether Industries has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on November 13, 2025.